top of page

Team
Our Mission of Discovery
At Halia Therapeutics we are discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.
Team

Alexis Mollard, PhD
Sr. Director Medicinal Chemistry

Devan Bursey
Scientist

Andrea "Andi" Groen
Director of Operations

Margit Janat-Amsbury, MD, PhD
Chief Medical Officer

Anya Neidig, MSN, RN
Director of Clinical Operations

Taylor Avei
Business Development Representative

bottom of page